Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
923 trades
$2B in total
Open-market sales
1,038 trades
$2.3B in total
Insiders filing
464 insiders
Last 7 days
Trade type
Rigel PharmaceuticalsRIGL
Open-market sale10b5-1 plan06/2206/242,500 sh$35.00$87,500−19.8%
Rigel PharmaceuticalsRIGL
Open-market sale10b5-1 plan05/2605/282,500 sh$29.17$72,925−16.5%
Rigel PharmaceuticalsRIGL
Open-market sale02/2002/244,000 sh$36.36$145,440−23.9%
CEO, President
Rigel PharmaceuticalsRIGL
Open-market sale25/02/04–25/02/0525/02/069,352 sh2 trades$21.40avg.$200,087.84−3.8%
EVP & CFO
Rigel PharmaceuticalsRIGL
Open-market sale25/02/04–25/02/0525/02/063,770 sh2 trades$21.38avg.$80,619.74−6.2%
EVP, GC, CCO & Corp Sec
Rigel PharmaceuticalsRIGL
Open-market sale25/02/04–25/02/0525/02/062,787 sh2 trades$21.41avg.$59,656.43−6.7%
EVP, Chief Commercial Officer
Rigel PharmaceuticalsRIGL
Open-market sale25/02/04–25/02/0525/02/063,921 sh2 trades$21.38avg.$83,841.28−7.0%
CEO, President
Rigel PharmaceuticalsRIGL
Open-market sale24/02/02–24/02/0524/02/0652,894 sh2 trades$1.14avg.$60,075.67−2.5%
EVP & CFO
Rigel PharmaceuticalsRIGL
Open-market sale24/02/02–24/02/0524/02/0612,628 sh2 trades$1.14avg.$14,339.91−3.0%
EVP, Chief Commercial Officer
Rigel PharmaceuticalsRIGL
Open-market sale24/02/02–24/02/0524/02/0614,519 sh2 trades$1.14avg.$16,495.65−4.0%
Rodriguez Raul R.CEO, President
Rigel PharmaceuticalsRIGL
Open-market sale23/02/0623/02/0720,340 sh$1.75$35,595−1.2%
Rigel PharmaceuticalsRIGL
Open-market sale23/02/0223/02/065,389 sh$1.66$8,945.74−2.7%
Rigel PharmaceuticalsRIGL
Open-market sale23/02/0223/02/065,389 sh$1.66$8,945.74−6.9%
Santos David A.EVP, Chief Commercial Officer
Rigel PharmaceuticalsRIGL
Open-market sale23/02/0223/02/065,388 sh$1.66$8,944.08−3.6%